Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: Theoretical and practical implications

Clinical Chemistry

Volumn 50, Issue 7, 2004, Pages 1113-1115

  Dobiášová, Milada ^a  

^a NONE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; PIOGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EDITORIAL; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; THEORY;

CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; PLASMA; RANDOMIZED CONTROLLED TRIALS; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 3042610458     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.033175     Document Type: Editorial

References (15)

1. Gilling L, Suwattee P, DeSouza C, Asnani S, Fonseca V. Effects of the thiazolidinediones on vascular risk factors. Am J Cardiovasc Drugs 2002;2:149-56.
2. Tan MH, Johns D, Glazer NB. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 2004;50:1184-8.
3. HDL). Clin Biochem 2001;34:583-8.
4. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000;43:148-55.
5. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96:2520-5.
6. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor to cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J Cardiovasc Risk 1996;3:213-9.
7. 1 and dense LDL in type 2 diabetes. Arterioscler Thromb Vasc Biol 2001;21:282-9.
8. Murakami T, Michelagnoli S, Longhi R, Gianfranceschini G, Pazzucconi F, Calabresi L, et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 1995;15:1819-28.
9. Dobiášová M, Frohlich J. Assays of lecithin cholesterol acyltransferase (LCAT). In: Ordovas JM, ed. Methods in molecular biology. Lipoprotein protocols. Totowa, NJ: Humana Press, 1998:217-30.
10. Rader DJ. High-density lipoprotein and atherosclerosis. Am J Cardiol 2002;92:62i-72i.
11. Barter PJ, Hopkins GJ, Calvert GD. Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochem J 1982;208:1-7.
12. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high-density lipoprotein receptor. Science 196;271:518-20.
13. Dobiášová M, Stříbrná J, Pritchard PH, Frohlich J. Cholesterol esterification rate in plasma depleted of very low and low density lipoproteins is controlled by the proportion of HDL2 and HDL3 subclasses: study in hypertensive and normal middle-aged and septuagenarian men. J Lipid Res 1992;33:1411-8.
14. HDL) and logarithmically transformed ratio of triglycerides to HDL-cholesterol. Physiol Res 2001;50:1-8.
15. Frohlich J, Dobiášová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 2003;49:1873-80.